---
schema_version: "secwatch.filing_event.v1"
accession: "0001932393-24-000033"
form_type: "8-K"
ticker: "GEHC"
cik: "0001932393"
company_name: "GE HealthCare Technologies Inc."
filed_at: "2024-04-30T23:59:59+00:00"
generated_at: "2026-06-03T04:50:37.157622+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# GE HealthCare reports Q1 2024 results: revenue flat organically, margins expand, reaffirms guidance

## Summary
- Revenues declined 1% to $4.6B; organic revenue approximately flat year-over-year.
- Net income margin improved to 8.0% from 7.9%; Adjusted EBIT margin rose to 14.7% from 14.1%.
- Diluted EPS increased to $0.81 from $0.41; Adjusted EPS rose to $0.90 from $0.85.
- Cash from operations $419M vs $468M; free cash flow $274M vs $325M; repaid $150M debt.
- Reaffirmed full-year 2024 guidance: ~4% organic revenue growth, Adjusted EPS $4.20-$4.35.

## SEC filing metadata
- accession: 0001932393-24-000033
- form_type: 8-K
- ticker: GEHC
- cik: 0001932393
- company_name: GE HealthCare Technologies Inc.
- filed_at: 2024-04-30T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1932393/000193239324000033/0001932393-24-000033-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1932393/000193239324000033/gehc-20240430.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001932393-24-000033
- JSON: https://secwatch.observer/filing/0001932393-24-000033.json
- Plain text: https://secwatch.observer/filing/0001932393-24-000033.txt

## Key facts
- Earnings Releases
  GE HealthCare Technologies Inc. reported the first quarter ended March 31, 2024 results: revenue $4.6 billion, net income $374 million, EPS $0.81. Guidance reaffirmed.
  - Period: the first quarter ended March 31, 2024
  - Revenue: $4.6 billion
  - Net income: $374 million
  - EPS: $0.81
  - Guidance: reaffirmed
  - Result: reported results
  source text: of 2024 consistent with our previous comments, and we remain on track to deliver our guidance for the year.” First Quarter 2024 Total Company Financial Performance • Revenues of $4.6 billion declined 1% r eported and were approximately flat on an Organic* basis year-over-year, with decreased volume partially offset by positive price. • Total company book-to-bill was
  evidence_url: https://www.sec.gov/Archives/edgar/data/1932393/000193239324000033/0001932393-24-000033-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.